breast cancer

(redirected from Breast carcinoma)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to Breast carcinoma: DCIS, fibroadenoma, Infiltrating ductal carcinoma
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.breast cancer - cancer of the breast; one of the most common malignancies in women in the US
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
References in periodicals archive ?
The basis of the association of granulomatous lobular mastitis and breast carcinoma is thought to be steroid and immunosuppressive agents used in treatment with chronic inflammation; but the pathogenesis has not yet been elucidated.
A Clinicopathologic Analysis of 45 Patients With Metaplastic Breast Carcinoma. Am J Clin pathol.
Early Breast Carcinoma is defined as "Tumour of not more than 5 cm in diameter with either palpable or impalpable axillary lymph node, but not fixed and no evidence of distant metastasis or by TNM classification it includes Stage I, IIa or IIb."
Wylie, "Screen-detected mucinous breast carcinoma: potential for delayed diagnosis," Clinical Radiology, vol.
Potential prognostic tumor biomarkers in triple-negative breast carcinoma. Beijing Da Xue Bao 2012; 44(5): 666- 72.
Occult primary breast carcinoma presenting as axillary lymphadenopathy accounts for less than 1% of all breast cancers.(15) MRI has been found to detect 64-75% of occult breast malignancies, with the average tumor size being 15 mm at detection.(16) In a study by Hong et al, MRI was found to have a low false-negative rate.
Key words: Argyrophilic Nucleolar Organizer Regions, Estrogen receptor, Breast carcinoma.
She was diagnosed as breast carcinoma 5 years back and got mastectomy done 2 years back.
[32] With advancement in the field of mammography, neo-adjuvant therapy, and breast conservation surgery in breast carcinoma, cytology grading can be used for selection of neoadjuvant therapy.
It is the immunodominant nonapeptide derived from the extracellular domain of the HER2 protein, a well-established target for therapeutic intervention in breast carcinoma.
Our work describes the expression of two different members of apoptotic regulatory pathway and their relationship with a progression of breast carcinoma. This approach could help with the development of effective antiangiogenic therapies, which require identifying biologically relevant molecular targets associated with increased tumour angiogenesis [6].

Full browser ?